Medical Diagnostics

Torreya has been involved in work in medical diagnostics from its inception.

Our team has a strong network within the diagnostics sector, extensive knowledge of the diagnostics marketplace and a track record of successfully concluded transactions.

Across the globe, pressures on healthcare system costs have caused spending on prevention to rise disproportionately. For example, in the United States the Affordable Care Act provides a strong incentive for the greater use of diagnostics oriented at screening for disease by generally leaving such spend out of consumer deductibles.

Advances in medical technology have been dramatic and have led to substantial growth across the diagnostics sector—from traditional areas like histopathology and IVD tests to newer areas in molecular diagnostics, genome sequencing and various novel tests based upon microRNA, protein fragments and the like.

Torreya Partners work in diagnostics has been varied but has focused to a significant degree on financing and strategic transactions involving new technologies. We have also been extensively involved in efforts at facilitating commercialization of diagnostics technologies.

 

Diagnostics Sector Team

Charles L. Dimmler III

Charles L. Dimmler III

Vice-Chairman

New York Office

(212) 257-5804

A venture capitalist, operating executive, advisor, and builder of life science businesses.

MORE »

Stephanie Léouzon

Stephanie Léouzon

Partner and Head of Torreya Partners Europe

London Office

+44 20 7451 4551

A leading life sciences advisor with over 20 years of experience.

MORE »

Tim Opler, Ph.D.

Tim Opler, Ph.D.

Partner

New York Office

(212) 257-5802

A life sciences industry advisor focused on managing client relationships for Torreya Partners.

MORE »

Alan Selby

Alan Selby

Executive Director

London Office

+44 (0)20 7451 4553

Active life sciences advisor in Europe.

MORE »